“For people with diabetes, insulin can be as essential as air,” said Steve Miller, Cigna’s executive vice president and chief clinical officer. “We need to ensure these individuals feel secure in their ability to afford every fill so they don’t miss one dose, which can be dangerous for their health.”
The move comes after criticism of drug companies that they've been overcharging for the lifesaving hormone, and some parents have blamed the pharmas for the deaths of their diabetic children when the drug costs soared to as much as $1,000 a month, CNN reported.
The American Diabetes Association said that six million Americans depend on insulin every day and that the escalating costs have become a major burden.
USA Today reported that studies show one out of four people with diabetes who need insulin will cut back on use of the drug over costs.